Shopping Cart
- Remove All
- Your shopping cart is currently empty
Ginsenoside F4 exerts inhibitory effects on human lymphocytoma JK cells by inducing apoptosis. The mechanism of action involves mitochondrial dysfunction, increased Bax expression, and reduced Bcl-2 expression, together resulting in programmed cell death.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $81 | In Stock | |
5 mg | $228 | In Stock | |
10 mg | $342 | In Stock | |
25 mg | $572 | In Stock | |
50 mg | $813 | In Stock |
Description | Ginsenoside F4 exerts inhibitory effects on human lymphocytoma JK cells by inducing apoptosis. The mechanism of action involves mitochondrial dysfunction, increased Bax expression, and reduced Bcl-2 expression, together resulting in programmed cell death. |
In vitro | Methods: Ginsenoside F4 (8.15 μM, 65.19 μM, 130.38 μM) was used to treat Homo sapiens lymphoblastoma JK cells, and the expression of related proteins was detected by Western Blot. Results: Ginsenoside F4 induced apoptosis in Homo sapiens lymphoblastoma JK cells by downregulating Bcl-2 protein and upregulating Bax protein levels, which are key regulators associated with apoptosis, demonstrating its antitumor effects. [1] |
Molecular Weight | 767.01 |
Formula | C42H70O12 |
Cas No. | 181225-33-2 |
Smiles | C[C@]12[C@@]3(C)[C@@]([C@@H](\C(=C\CC=C(C)C)\C)CC3)([C@H](O)C[C@@]1([C@]4(C)[C@@]([C@@H](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O6)[C@@H](O)[C@H](O)[C@@H](CO)O5)C2)(C(C)(C)[C@@H](O)CC4)[H])[H])[H] |
Relative Density. | 1.28 g/cm3 at 20℃ |
Color | White |
Appearance | Solid |
Storage | keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 40 mg/mL (52.15 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.